AVITA Medical (NASDAQ:RCEL) vs. RenovaCare (OTCMKTS:RCAR) Head-To-Head Analysis

RenovaCare (OTCMKTS:RCAR) and AVITA Medical (NASDAQ:RCEL) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

Institutional & Insider Ownership

27.7% of AVITA Medical shares are owned by institutional investors. 0.9% of RenovaCare shares are owned by company insiders. Comparatively, 1.8% of AVITA Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Earnings and Valuation

This table compares RenovaCare and AVITA Medical’s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RenovaCare	N/A	N/A	-$4.47 million	N/A	N/A
AVITA Medical	$54.14 million	4.34	-$35.38 million	($1.76)	-5.18

RenovaCare has higher earnings, but lower revenue than AVITA Medical.

Volatility & Risk

RenovaCare has a beta of -99.27, suggesting that its stock price is 10,027% less volatile than the S&P 500. Comparatively, AVITA Medical has a beta of 1.54, suggesting that its stock price is 54% more volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and recommmendations for RenovaCare and AVITA Medical, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RenovaCare	0	0	0	0	N/A
AVITA Medical	0	2	1	0	2.33

AVITA Medical has a consensus price target of $15.00, suggesting a potential upside of 64.65%.

Profitability

This table compares RenovaCare and AVITA Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
RenovaCare	N/A	N/A	N/A
AVITA Medical	-88.41%	-84.07%	-47.63%

Summary

AVITA Medical beats RenovaCare on 5 of the 9 factors compared between the two stocks.

About RenovaCare

RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs. The company was formerly known as Janus Resources, Inc. and changed its name RenovaCare, Inc.,to RenovaCare, Inc. in January 2014. RenovaCare, Inc. was incorporated in 1983 and is based in Scottsdale, Arizona.

About AVITA Medical

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.